TISLELIZUMAB
Clinical trials for TISLELIZUMAB explained in plain language.
Never miss a new study
Get alerted when new TISLELIZUMAB trials appear
Sign up with your email to follow new studies for TISLELIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets 'Hidden' colon cancer after chemo
Disease control Recruiting nowThis study is testing whether a combination of two drugs, fruquintinib and tislelizumab, can help control colorectal cancer in patients who have finished their initial chemotherapy but still have tiny amounts of cancer left in their body, detected by a special blood test. The goa…
Matched conditions: TISLELIZUMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 06:20 UTC
-
Gut bacteria boost for rectal cancer treatment?
Disease control Recruiting nowThis study is testing if adding a specific probiotic supplement (Probio-M9) to a standard treatment plan improves results for people with locally advanced rectal cancer. All participants will receive chemotherapy, radiation, and an immunotherapy drug (tislelizumab). Researchers w…
Matched conditions: TISLELIZUMAB
Phase: PHASE2 • Sponsor: Seventh Medical Center of PLA General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat lung cancer patients
Disease control Recruiting nowThis study is testing a specific treatment sequence for people with advanced non-small cell lung cancer who cannot handle standard concurrent chemoradiation. It involves giving chemotherapy first, followed by a shorter, more intense course of radiation, combined with an immunothe…
Matched conditions: TISLELIZUMAB
Phase: PHASE2 • Sponsor: Zibo Municipal Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo aims to zap tumors, save kidneys
Disease control Recruiting nowThis study is testing whether a combination of two drugs, tislelizumab and nab-paclitaxel, can effectively treat a type of kidney cancer located in the renal pelvis. The main goal is to control the cancer for at least one year while avoiding the need to surgically remove the enti…
Matched conditions: TISLELIZUMAB
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC